Hutton Scott's Insider Trades & SAST Disclosures
Hutton Scott's most recent trade in Biodesix Inc was a trade of 12,212 Common Stock done . Disclosure was reported to the exchange on May 9, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Hutton Scott.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Biodesix Inc | Scott Hutton | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2025 | 12,212 | 724,159 | - | - | Common Stock | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2025 | 12,212 | 36,636 | - | - | Restricted Stock Units | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 0.36 per share. | 09 May 2025 | 1,888 | 722,271 | - | 0.4 | 679 | Common Stock |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 0.35 per share. | 09 May 2025 | 1,887 | 720,384 | - | 0.4 | 666 | Common Stock |
| Biodesix Inc | Hutton Scott | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 775,000 | 775,000 | - | - | Stock Options (Right to buy) | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 425,929 | 425,929 | - | - | Stock Options (Right to buy) | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 387,500 | 387,500 | - | - | Restricted Stock Units | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 252,628 | 785,607 | - | - | Common Stock | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 187,760 | 375,521 | - | - | Restricted Stock Units | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 0.92 per share. | 10 Feb 2025 | 83,660 | 701,947 | - | 0.9 | 77,319 | Common Stock |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 52,656 | 157,969 | - | - | Restricted Stock Units | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 12,212 | 48,848 | - | - | Restricted Stock Units | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Nov 2024 | 12,212 | 61,060 | - | - | Restricted Stock Units | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Nov 2024 | 12,212 | 536,719 | - | - | Common Stock | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 1.39 per share. | 08 Nov 2024 | 1,927 | 534,792 | - | 1.4 | 2,680 | Common Stock |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 1.40 per share. | 08 Nov 2024 | 1,813 | 532,979 | - | 1.4 | 2,540 | Common Stock |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2024 | 12,212 | 522,112 | - | - | Common Stock | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2024 | 12,212 | 73,272 | - | - | Restricted Stock Units | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 1.60 per share. | 08 Aug 2024 | 2,781 | 519,331 | - | 1.6 | 4,452 | Common Stock |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 1.57 per share. | 08 Aug 2024 | 963 | 518,368 | - | 1.6 | 1,514 | Common Stock |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2024 | 26,120 | 509,900 | - | - | Common Stock | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2024 | 653 | 0 | - | - | Series A Non-Voting Convertible Preferred Stock | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2024 | 12,212 | 85,484 | - | - | Restricted Stock Units | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2024 | 12,212 | 487,544 | - | - | Common Stock | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 1.48 per share. | 08 May 2024 | 3,764 | 483,780 | - | 1.5 | 5,569 | Common Stock |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2024 | 653 | 653 | - | - | Series A Non-Voting Convertible Preferred Stock | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 180,926 | 180,926 | - | - | Stock Options (Right to buy) | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 421,250 | 421,250 | - | - | Stock Options (Right to buy) | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 210,625 | 210,625 | - | - | Restricted Stock Units | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 199,973 | 529,401 | - | - | Common Stock | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 187,761 | 563,281 | - | - | Restricted Stock Units | |
| Biodesix Inc | Hutton Scott | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 1.92 per share. | 08 Feb 2024 | 34,682 | 494,719 | - | 1.9 | 66,472 | Common Stock |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 1.66 per share. | 08 Feb 2024 | 29,708 | 465,011 | - | 1.7 | 49,455 | Common Stock |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 12,212 | 97,696 | - | - | Restricted Stock Units | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2023 | 44,777 | 331,795 | - | - | Common Stock | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2023 | 32,565 | 0 | - | - | Restricted Stock Units | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2023 | 12,212 | 122,120 | - | - | Restricted Stock Units | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 1.39 per share. | 08 Aug 2023 | 6,893 | 324,902 | - | 1.4 | 9,570 | Common Stock |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 1.27 per share. | 08 Aug 2023 | 6,889 | 318,013 | - | 1.3 | 8,728 | Common Stock |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 1.62 per share. | 03 Aug 2023 | 46,296 | 287,018 | - | 1.6 | 75,000 | Common Stock |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2023 | 44,778 | 254,504 | - | - | Common Stock | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2023 | 32,566 | 32,565 | - | - | Restricted Stock Units | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2023 | 12,212 | 134,332 | - | - | Restricted Stock Units | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 1.57 per share. | 08 May 2023 | 9,934 | 244,570 | - | 1.6 | 15,561 | Common Stock |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 1.58 per share. | 08 May 2023 | 3,848 | 240,722 | - | 1.6 | 6,065 | Common Stock |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 435,668 | 435,668 | - | - | Stock Options (Right to buy) | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 751,042 | 751,042 | - | - | Restricted Stock Units | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2023 | 44,777 | 216,004 | - | - | Common Stock | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2023 | 32,565 | 65,131 | - | - | Restricted Stock Units | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 1.80 per share. | 08 Feb 2023 | 16,278 | 199,726 | - | 1.8 | 29,286 | Common Stock |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2023 | 12,212 | 146,544 | - | - | Restricted Stock Units | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 1.15 per share. | 21 Nov 2022 | 65,217 | 171,227 | - | 1.2 | 75,000 | Common Stock |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Nov 2022 | 44,778 | 119,787 | - | - | Common Stock | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Nov 2022 | 32,566 | 97,696 | - | - | Restricted Stock Units | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Nov 2022 | 12,212 | 158,756 | - | - | Restricted Stock Units | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 1.04 per share. | 08 Nov 2022 | 7,690 | 112,097 | - | 1.0 | 8,011 | Common Stock |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 1.02 per share. | 08 Nov 2022 | 6,087 | 106,010 | - | 1.0 | 6,194 | Common Stock |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2022 | 44,777 | 88,643 | - | - | Common Stock | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2022 | 32,565 | 130,262 | - | - | Restricted Stock Units | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 2.53 per share. | 08 Aug 2022 | 13,634 | 75,009 | - | 2.5 | 34,469 | Common Stock |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2022 | 12,212 | 170,968 | - | - | Restricted Stock Units | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2022 | 44,778 | 57,144 | - | - | Common Stock | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2022 | 32,566 | 162,827 | - | - | Restricted Stock Units | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 1.83 per share. | 09 May 2022 | 13,278 | 43,866 | - | 1.8 | 24,299 | Common Stock |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2022 | 12,212 | 183,180 | - | - | Restricted Stock Units | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2022 | 195,393 | 195,393 | - | - | Restricted Stock Units | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2022 | 195,392 | 195,392 | - | - | Restricted Stock Units | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 6.46 per share. | 17 Nov 2021 | 3,000 | 9,762 | - | 6.5 | 19,375 | Common Stock |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Feb 2021 | 255,688 | 0 | - | - | Stock Options (Right to buy) | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 255,688 | 255,688 | - | - | Stock Options (Right to buy) | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 115,203 | 115,203 | - | - | Stock Options (Right to buy) | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Feb 2021 | 115,203 | 0 | - | - | Stock Options (Right to buy) | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 85,875 | 85,875 | - | - | Stock Options (Right to buy) | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 75,693 | 75,693 | - | - | Stock Options (Right to buy) | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 8,423 | 8,423 | - | - | Stock Options (Right to buy) | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 8,423 | 16,846 | - | - | Stock Options (Right to buy) | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 18.00 per share. | 30 Oct 2020 | 5,500 | 5,500 | - | 18 | 99,000 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges